| APP | acute phase protein; alum-precipitated pyridine; aminopyrazolopyrimidine; amyloid peptide precursor;... |
|---|---|
| APRP | acidic proline-rich protein; acute phase reactant protein |
| ARP | absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro... |
| BP | Bachelor of Pharmacy; back pressure; barometric pressure; basic protein; bathroom privileges; bed pa... |
| CMP | cardiomyopathy; cartilage matrix protein; chondromalacia patellae; collagen binding protein; competi... |
| PKN protein kinase | <enzyme> Catalytic domain homologous to protein kinase c; genbank d26181 (human) and genbank d26180 (rat); do not confuse with protein kinase n Registry number: EC 2.7.1.- (26 Jun 1999) |
|---|---|
| placental calcium-binding protein | <protein> Calcium binding protein of placenta, uterus and vasculature containing the EF hand motif. (18 Nov 1997) |
| placenta protein | human placental lactogen |
| whey protein | The soluble protein contained in the whey of milk clotted by rennin; e.g., lactoglobulin, alpha-lactalbumin, lactoferrin. (05 Mar 2000) |
| motor protein | <protein> Proteins that bind ATP and are able to move on a suitable substrate with concomitant ATP hydrolysis. most eukaryotic motor proteins move by binding to a specific site on either actin filaments (myosin) or on microtubules (dynein, kinesin). They are normally elongated molecules with two active binding sites although some kinesin analogues have a single site. The distal end of the molecule normally binds adaptor proteins that enable them to make stable interactions with membranous vesicles or with filamentous structures, which then constitute the cargo to be moved along the substrate filament. (18 Nov 1997) |
| M protein | 1. Galactoside carrier in E. Coli 2. Cell surface antigen of Brucella. 3. Structural protein in the M line of striated muscle (myomesin). (4) Cell wall protein of streptococci: antibody typing of the M protein is important in identification of different strains of Group A streptococci (at least 55 serotypes are known). The M protein confers antiphagocytic properties on the cell and is present as hair like fimbriae on the surface. M protein is an important virulence factor and antibodies directed against M protein are essential for phagocytic killing of the bacteria. (18 Nov 1997) |
| plasma protein | <haematology> One of the hundreds of different proteins present in blood plasma, including carrier proteins (such albumin, transferrin and haptoglobin), fibrinogen and other coagulation factors, complement components, immunoglobulins, enzyme inhibitors, precursors of substances such as angiotension and bradykinin and many other types of proteins. (14 Oct 1997) |
| MST1 protein kinase | <enzyme> Mst1 - mammalian sterile twenty-like; homologous to ste20; genbank u18297; do not confuse with the monosaccharide transporter mst1 protein Registry number: EC 2.7.10.- (26 Jun 1999) |
| compound protein | A protein that contains atleast one prosthetic group. (09 Oct 1997) |
| Win1 protein kinase | <enzyme> A map kinase kinase (mapkk) responsible for osmostress signaling; isolated from schizosaccharomyces pombe Registry number: EC 2.7.10.- Synonym: win1 gene product (26 Jun 1999) |
| platelet basic protein | <protein> Protein that is the precursor of connective tissue activating peptide III and _ thromboglobulin. (18 Nov 1997) |
| wis1 protein kinase | <enzyme> A map kinase kinase homolog; has homology to the serine-threonine family of protein kinases; genbank u81521 Registry number: EC 2.7.10.- Synonym: wis1 gene product, wik1 gene product (26 Jun 1999) |
| Wis4 protein kinase | <enzyme> A map kinase kinase kinase (mapkkk); phosphorylates wis1; genbank y07750 Registry number: EC 2.7.10.- Synonym: wis4 gene product (26 Jun 1999) |
| MUK protein kinase | <enzyme> Related to mapkkk proteins; activates jnk/sapk pathway; genbank d49785 Registry number: EC 2.7.1.- Synonym: protein kinase muk (26 Jun 1999) |
| congenital protein C or s deficiency | This inherited disorder of blood coagulation is characterised by a deficiency of vitamin K dependent plasma proteins (C and s) that are naturally occurring anticoagulants. This disorder results in an increased risk of blood clot formation within the circulatory system. (27 Sep 1997) |